While dapagliflozin (DAPA), a sodium-glucose cotransporter 2 inhibitor, has proven clinical benefits in HF, its molecular mechanisms remain unclear.<h4>Methods</h4>We integrated bulk and single-cell transcriptomic analyses with experimental validation to investigate the role of STAT1 in HF and its modulation by DAPA. Here, STAT1 is linked to hydrops fetalis.